Publications by authors named "Hugo Valencia"

Claim this Profile
A
A study of the MAYV replication cycle: Correlation between the kinetics of viral multiplication and viral morphogenesis.
Diogo C Mendonça, Erik V S Reis, Nídia E C Arias, Hugo J Valencia, Cláudio A Bonjardim

Virus Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEK/ERK activation plays a decisive role in Zika virus morphogenesis and release.
Hugo José Valencia, Diogo Corrêa Mendonça, Paula Eillanny Silva Marinho, Lethícia Ribeiro Henriques, Betânia Paiva Drumond

Arch Virol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological Analysis of COVID-19 Cases in Native Amazonian Communities from Peru.
Cecilia Pajuelo-Reyes, Hugo J Valencia, Carla C Montenegro, Eduardo Quezada, Lizandro Gonzales

Epidemiologia (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.
Katharine A Collier, Hugo Valencia, Herbert Newton, Erinn M Hade, Douglas W Sborov

Cancer Chemother Pharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of kinase inhibitors as potential therapeutics for flavivirus infections.
Hugo J Valencia, Mara C A M de Aguiar, Mariana A Costa, Diogo C Mendonça, Erik V Reis

Arch Virol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive pulmonary aspergillosis in a patient with cirrhosis.
Heather L Clark, Hugo E Valencia, Jennifer J Findeis-Hosey, Steve N Georas

IDCases· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic and clinical characteristics of chikungunya patients from six Colombian cities, 2014-2015.
Juan C Rueda, Ana M Santos, Jose-Ignacio Angarita, Rodrigo B Giraldo, Eugenia-Lucia Saldarriaga, Hugo Valencia

Emerg Microbes Infect· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies.
AnnaLynn M Williams, Andrea M Baran, Philip J Meacham, Megan M Feldman, Hugo E Valencia

Leuk Lymphoma· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.
Patricia Sheen, Katherine Lozano, Robert H Gilman, Hugo J Valencia, Sebastian Loli

Tuberculosis (Edinb)· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac rehabilitation participation in underserved populations. Minorities, low socioeconomic, and rural residents.
Hugo E Valencia, Patrick D Savage, Philip A Ades

J Cardiopulm Rehabil Prev· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A20-binding inhibitor of nuclear factor-kappaB (NF-kappaB)-2 (ABIN-2) is an activator of inhibitor of NF-kappaB (IkappaB) kinase alpha (IKKalpha)-mediated NF-kappaB transcriptional activity.
Laurent Leotoing, Fanny Chereau, Silvère Baron, Florent Hube, Hugo J Valencia

J Biol Chem· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis